BioMelbourne News

New report aims to broaden understanding of how new medicines are funded in Australia

– Stakeholders debate future of medicines funding system at launch event A new report, developed by GlaxoSmithKline Australia (GSK) and ViiV Healthcare (ViiV) will be launched as part of an initiative to raise understanding of the medicines development…

2017 – A Big Year for Biotech!

Our vision for Victoria is to lead the world in health innovation. Discovering, developing and manufacturing the health technologies that change the world. New drugs, devices, diagnostics, vaccines, therapies and digital products – Victoria is the best place to…

Media Release – Industry calls for Medical Technologies and Pharmaceuticals Innovation Hub

Media Release – Monday 20th November 2017 At its Annual General Meeting today, BioMelbourne Network will launch a pre-budget submission calling for the Victorian Government to invest in a Medical Technologies and Pharmaceuticals Innovation Hub in Melbourne. The Hub…

BioMelbourne Network submission to the Policy Consultation Paper – Visa Simplification: Transforming Australia’s Visa System

“Australia’s visa system must remain globally competitive to attract talent to build future industries and transition to a knowledge-led economy” Health is a global market and access to global talent is critical for healthcare innovation. Companies need to…

Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics

We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…

Ask Industry Anything (Again) – Tuesday 28th November 2017

BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…

BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017

With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…

BioMelbourne Network Welcomes Revisions to Skilled Migration Visas

Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to the Medium…

2017 Connecting Women – Charity Announced!

The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…

Joint statement on the Research & Development Tax Incentive 18 April 2017

Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…

Launch of Global Health Alliance Melbourne

Global Health Alliance Melbourne (GLHAM) is an alliance for development and health equity in the Asia-Pacific, and is modelled on the highly successful Washington Global Health Alliance (link). The Alliance aims to optimise the collective capabilities of Melbourne-based…

Lusia Guthrie appointed to role of BioMelbourne Network Interim CEO

BioMelbourne Network is delighted to announce that after a thorough selection process, the Board has engaged Lusia Guthrie in the role of Interim CEO. Lusia will be responsible for the day to day management of the Association whilst Krystal…

Home

News & opinion

Member Directory

Events